CONGENITAL DYSFIBRINOGENAEMIA

This adverse event was reported 12 times

CONGENITAL DYSFIBRINOGENAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FIBRINOGEN HUMAN 2 0.0086
1 ESOMEPRAZOLE MAGNESIUM DIHYDRATE 9 0.0006
2 MESALAMINE 12 0.0004
3 AZATHIOPRINE 12 0.0001
4 RANITIDINE HYDROCHLORIDE 6 0.0001
5 ESOMEPRAZOLE MAGNESIUM 12 0.0001
6 RANITIDINE 6 0.0000
See all drugs enriched for association with CONGENITAL DYSFIBRINOGENAEMIA

These drug classes are most commonly taken by patients reporting CONGENITAL DYSFIBRINOGENAEMIA:

# Drug class Count
0 Aminosalicylate [EPC] 12
1 Proton Pump Inhibitor [EPC] 12
2 Purine Antimetabolite [EPC] 12
3 Human Blood Coagulation Factor [EPC] 2
See all common drug classes associated with CONGENITAL DYSFIBRINOGENAEMIA

CONGENITAL DYSFIBRINOGENAEMIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Blood Coagulation Factor [EPC] 2 0.0024
1 Purine Antimetabolite [EPC] 12 0.0001
2 Aminosalicylate [EPC] 12 0.0001
3 Proton Pump Inhibitor [EPC] 12 0.0000
See all drug classes enriched for association with CONGENITAL DYSFIBRINOGENAEMIA